Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

2.95
BATS BZX Real-Time Price
As of 3:04pm ET
 -0.04 / -1.34%
Today’s Change
2.69
Today|||52-Week Range
5.66
+2.43%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close2.99
Today’s open3.01
Day’s range2.90 - 3.02
Volume89,695
Average volume (3 months)2,227,645
Market cap$412.2M
Data as of 3:04pm ET, 01/16/2018

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-37.33%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc-0.60-2.92%
VSARVersartis Inc-0.02-1.16%
SGYPSynergy Pharmaceutic...-0.12-5.02%
INSYINSYS Therapeutics I...+0.27+3.05%
Data as of 3:03pm ET, 01/16/2018

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
Chief Operating Officer &
Executive Vice President
Joseph Truitt
Corporate headquarters
New Haven, Connecticut

Forecasts